Acumen Pharma - ABOS Net earnings per one share for the last twelve months

Acumen Pharmaceuticals Inc. (ABOS) - corporate logo

The business model of Acumen Pharmaceuticals (ABOS) relies on the efficacy of ACU193 in treating Alzheimer's disease, where the key success factor will be the slowing of cognitive decline. A management team composed of specialized scientists is betting on the flawless precision of clinical trials. This chart of the market price demonstrates an EPS (TTM) of 30.20, while R&D development is supported by co-financing from a major global partner.

ABOS: acumenpharm.com Net earnings per share for the last 12 months 02/11/2024 - 11/15/2026

Acumen Pharmaceuticals - analytical breakdowns and key metrics (ABOS)

- market value and analyst target forecast:
Stock Quotes Acumen Pharmaceuticals, Inc.|ABOS - Analyst Consensus Forecast
- issuer market value details:
Market Value Acumen Pharmaceuticals, Inc|ABOS - Total Company Value
- company book value details:
Equity per Share Acumen Pharmaceuticals|ABOS - Company Net Assets|Market Value to Book Value acumenpharm.com|ABOS - Aggregate Company Assets
- debt and liquidity data:
Aggregate Debt to Equity Acumen Pharmaceuticals|ABOS - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Acumen Pharmaceuticals|ABOS - Company Aggregate Debts|Debts to Book Capitalization Acumen Pharmaceuticals, Inc|ABOS - Company Long-Term Debt|Company Short-Term Loans and Borrowings Acumen Pharmaceuticals|Quick Liquidity Indicator acumenpharm.com
- earnings and valuation multiples information:
ABOS - Net Profit|Projected Future Earnings Acumen Pharmaceuticals|ABOS - P/E Multiple|Projected Price to Earnings Acumen Pharma|ABOS - PEG Multiple|Company Value to EBITDA Acumen Pharmaceuticals|ABOS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Acumen Pharmaceuticals|ABOS - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months acumenpharm.com|ABOS - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Acumen Pharmaceuticals
- sales volume and revenue information:
ABOS - Revenue and Sales Volume|Company Future Sales Volume Acumen Pharmaceuticals, Inc.|ABOS - P/S Multiple|Forward P/S Multiple Acumen Pharmaceuticals, Inc
Fundamental company valuation:ABOS - Acumen Pharmaceuticals Inc.
Brand item of Acumen Pharmaceuticals, Inc

This indicator captures the dynamics of earnings per share compared to the same period last year, identifying deviations of current profitability from historical averages. By analyzing the annual EPS growth rate over the last 12 months, an investor will observe high volatility in the metrics of Acumen Pharmaceuticals (ABOS), driven by a lack of revenue and intensive R&D expenditures for Alzheimer's disease treatments.

Competitor analysis

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months CervoMed Corporation (CRVO)|Net earnings per share (EPS TTM) Alterity Therapeutics Ltd (ATHE)|Earnings per share for the last twelve months clene.com CLNN|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|AIFF (Firefly Neuro) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics, Ltd. (NRSN)|Reviva Pharmaceuticals - Earnings per share for the last 12 months|MetaVia Inc - Net earnings per share for the last 12 months|NRXS: Earnings per share for the last 12 months|HSDT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters passagebio.com PASG|NEUP (Neuphoria Therapeutics) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months minervaneurosciences.com (NERV)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Cortigent Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Avenue Therapeutics, Inc|BCLI (Brainstorm Cell Therapeutics, Inc.) - Net earnings per share for the last 12 months|Cara Therapeutics, Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corp|Net earnings per one share for the last twelve months eliemtx.com ELYM|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE